CTRI/2018/12/016574已完成3 期
A multicentre, double blind, randomized, parallel group, clinical trial to compare the sexual pleasure, performance, acceptability and safety of graphene incorporated natural rubber latex condoms and natural rubber latex condoms in healthy humans. -
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 156
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Healthy sexually active mutually monogamous heterosexual couples
- •2. Subject at least 18 years of age, able to provide informed consent.
- •3. Subject who are willing and able to take part and attend all required clinical trial visits, able to understand the information given to them and give written consent.
- •4. Subjects are in good health as confirmed by medical history, physical and gynecological examination.
- •5. Male partner must have used at least one condom during the 12 months prior to the study.
- •6. Subjects are not currently using any method of contraception other than the condom and are agreeable to getting pregnant during the 6 months study period.
排除标准
- •1.Women who are pregnant or suspected to be pregnant.
- •2.Women who have had a pelvic inflammatory disease, have untreated acute cervicitis or vaginitis, have the history of thrombophlebitis, have known or suspected uterine/cervical and breast malignancy.
- •3.Presence or history of allergy or sensitivity to topical vaginal products latex, or any other investigation products.
- •4.Currently active or a history of recurrent sexually transmitted infection (STI) including human immunodeficiency virus (HIV) infection in one or either partner.
- •5.Multiple sexual partners.
- •6.Participation in a clinical trial in the previous month which could, in the opinion of the investigator, affect the outcome of the investigation.
- •7.Male partners with a known history of erectile or ejaculatory dysfunction or abnormal penile anatomy that would affect the ability to keep the condom in place during intercourse.
- •8.Female partner suffering from vaginal dryness or using medication which would affect vaginal mucosal secretion, such as Chlorpheniramine.
- •9.Use of birth control methods other than the condom as part of the study.
- •10.Male or female partner with genital piercing.
- •11.Male partners using medication that would affect the ability to obtain and maintain an erection to normal ejaculation.
- •12.Male partner with the diagnosis of penile skin condition within previous three months (e.g. conditions associated with balanoposthitis: penile psoriasis, lichen sclerosis, eczema) as confirmed by subject and by genital examination.
研究者
相似试验
尚未招募
3 期
A study to compare the sexual pleasure, performance, acceptability and safety of graphene incorporated natural rubber latex condoms and natural rubber latex condoms.Performance, acceptability and safety of male condomPACTR201902647164097HLL Lifecare Limited90
已完成
2 期
A multicenter, double blind, randomized, parallel group, placebo-controlled study to evaluate the hemodynamic responses to intravenous RLX030 infusion in subjects with acute heart failure.Acute Heart Faillure10019280NL-OMON37099ovartis10
进行中（未招募）
1 期
Effects of intravenous serelaxin infusion on micro- and macrovascular function in patients with coronary artery diseaseCoronary artery diseaseMedDRA version: 18.1 Level: PT Classification code 10011078 Term: Coronary artery disease System Organ Class: 10007541 - Cardiac disordersEUCTR2012-001945-42-GBovartis Pharma Service AG58
进行中（未招募）
不适用
Hemodynamic responses to intravenous RLX030 infusion in patients with acute heart failureMedDRA version: 14.1Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersAcute Heart FailureEUCTR2011-000833-35-PLovartis Pharma Services AG70
进行中（未招募）
1 期
A multicenter, randomized, double blind, parallel group, vehicle controlled, study of the safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 8 weeks in pediatric subjects (2 to 12 years of age) with mild to moderate plaque psoriasisPsoriasisEUCTR2014-001744-38-BEGALDERMA R&D, LLC300